Lexology February 25, 2025
Latham & Watkins LLP

Click here to listen to the audio.

One of the country’s largest healthcare conferences recently concluded in San Francisco. Join the Latham team to discuss takeaways from the conference, including AI innovation and increased dealmaking activity, and consider the policy outlook under the new Trump administration.

Stakeholders from across the healthcare and biopharmaceutical industry recently...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator
Private equity deal would set stage for 3-way Walgreens split: Report
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M
AI Accelerates Discovery of Genes Linked to Neurodevelopmental Disorders
The Current, Future Roles of AI within the Pharmacy Profession

Share This Article